NYSE:TEVA

Teva Pharmaceutical Industries News Headlines

$9.71
-0.14 (-1.42 %)
(As of 08/3/2021 09:57 AM ET)
Add
Compare
Today's Range
$9.65
$9.92
50-Day Range
$8.38
$11.53
52-Week Range
$8.24
$13.30
Volume29,695 shs
Average Volume12.25 million shs
Market Capitalization$10.61 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.45

Teva Pharmaceutical Industries (NYSE TEVA) News Headlines Today

SourceHeadline
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Cut to $14.00Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Cut to $14.00
marketbeat.com - July 29 at 9:19 AM
3 ADRs to Spruce up Your International Exposure3 ADRs to Spruce up Your International Exposure
marketbeat.com - April 27 at 3:49 PM
Q3 2021 EPS Estimates for Teva Pharmaceutical Industries Limited (NYSE:TEVA) Reduced by AnalystQ3 2021 EPS Estimates for Teva Pharmaceutical Industries Limited (NYSE:TEVA) Reduced by Analyst
americanbankingnews.com - August 2 at 1:34 AM
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Given Consensus Recommendation of "Hold" by AnalystsTeva Pharmaceutical Industries Limited (NYSE:TEVA) Given Consensus Recommendation of "Hold" by Analysts
americanbankingnews.com - August 1 at 9:30 AM
Glioma Therapeutics Market Industry Size, Competition, Trends and Growth Opportunities by Region 2021-2028Glioma Therapeutics Market Industry Size, Competition, Trends and Growth Opportunities by Region 2021-2028
marketwatch.com - July 29 at 8:00 PM
Teva Pharmaceutical Industries (NYSE:TEVA) Announces  Earnings ResultsTeva Pharmaceutical Industries (NYSE:TEVA) Announces Earnings Results
americanbankingnews.com - July 29 at 6:46 PM
TEVA Q2 Earnings Beat Estimates, Revenues Miss, Stock UpTEVA Q2 Earnings Beat Estimates, Revenues Miss, Stock Up
finance.yahoo.com - July 29 at 3:00 PM
Teva Pharmaceutical Industries (NYSE:TEVA) Given New $11.00 Price Target at Wells Fargo & CompanyTeva Pharmaceutical Industries (NYSE:TEVA) Given New $11.00 Price Target at Wells Fargo & Company
americanbankingnews.com - July 29 at 12:42 PM
Raymond James Cuts Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $14.00Raymond James Cuts Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $14.00
americanbankingnews.com - July 29 at 12:05 PM
Teva Pharmaceutical Industries (TEVA) Q2 2021 Earnings Call TranscriptTeva Pharmaceutical Industries (TEVA) Q2 2021 Earnings Call Transcript
msn.com - July 28 at 11:42 PM
Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Down to $8.92Teva Pharmaceutical Industries (NYSE:TEVA) Shares Gap Down to $8.92
americanbankingnews.com - July 28 at 10:51 AM
Teva Lowers FY Revenues Outlook Teva Lowers FY Revenues Outlook
markets.businessinsider.com - July 28 at 7:35 AM
Clozapine Market Growth 2021, Segment Analysis, Major Manufacturers, with Industry Share, Current Market Trends and Future Scope Till 2027Clozapine Market Growth 2021, Segment Analysis, Major Manufacturers, with Industry Share, Current Market Trends and Future Scope Till 2027
marketwatch.com - July 23 at 11:33 PM
Global Peptide Therapeutics Market Size 2021 Company Overview, Growth and Forecast by 2026 Latest Research Report by Industry ExpertsGlobal Peptide Therapeutics Market Size 2021 Company Overview, Growth and Forecast by 2026 Latest Research Report by Industry Experts
marketwatch.com - July 22 at 12:06 PM
 Analysts Expect Teva Pharmaceutical Industries Limited (NYSE:TEVA) Will Announce Earnings of $0.58 Per Share Analysts Expect Teva Pharmaceutical Industries Limited (NYSE:TEVA) Will Announce Earnings of $0.58 Per Share
americanbankingnews.com - July 21 at 11:04 PM
Injectable Drug Delivery Devices Market Growth 2021 with Top Manufacturers, Future Trend, Demand, Industry Size with Covid-19 Impact till 2026Injectable Drug Delivery Devices Market Growth 2021 with Top Manufacturers, Future Trend, Demand, Industry Size with Covid-19 Impact till 2026
marketwatch.com - July 20 at 12:28 PM
Drugs for Herpes Labialis (Oral Herpes) Market Key Players, Industry Demand, Overview And Supply Chain Analysis, Forecast To 2026Drugs for Herpes Labialis (Oral Herpes) Market Key Players, Industry Demand, Overview And Supply Chain Analysis, Forecast To 2026
marketwatch.com - July 20 at 12:28 PM
Is TEVA A Good Stock To Buy?Is TEVA A Good Stock To Buy?
finance.yahoo.com - July 20 at 12:28 PM
Insights on the Losartan Global Market to 2026 - Featuring Pfizer, Teva Pharmaceutical Industries and Sanofi Among OthersInsights on the Losartan Global Market to 2026 - Featuring Pfizer, Teva Pharmaceutical Industries and Sanofi Among Others
finance.yahoo.com - July 20 at 7:27 AM
Pharmaceutical Co Ltd Takeda Sells 18,746 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) StockPharmaceutical Co Ltd Takeda Sells 18,746 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) Stock
americanbankingnews.com - July 19 at 7:34 PM
Teva Pharmaceutical Industries (NYSE:TEVA) Sets New 1-Year Low at $8.38Teva Pharmaceutical Industries (NYSE:TEVA) Sets New 1-Year Low at $8.38
americanbankingnews.com - July 19 at 10:49 AM
TEVA August 27th Options Begin TradingTEVA August 27th Options Begin Trading
nasdaq.com - July 8 at 1:36 PM
Specialty Generic Drugs Market to Set Phenomenal Growth by 2026 | Mallinckrodt, Apotex, Teva Pharmaceuticals USASpecialty Generic Drugs Market to Set Phenomenal Growth by 2026 | Mallinckrodt, Apotex, Teva Pharmaceuticals USA
marketwatch.com - July 7 at 8:50 AM
Glioma Therapeutics Market Report 2021 – Global Industry Size, Competition, Trends and Growth Opportunities to 2028Glioma Therapeutics Market Report 2021 – Global Industry Size, Competition, Trends and Growth Opportunities to 2028
marketwatch.com - July 1 at 6:33 PM
TEVA August 13th Options Begin TradingTEVA August 13th Options Begin Trading
nasdaq.com - July 1 at 1:21 PM
Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021
finance.yahoo.com - July 1 at 1:21 PM
New York Takes Drugmakers, Drug Retailers To Legal Trial Over OpioidNew York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid
benzinga.com - June 29 at 3:44 PM
New York takes Teva, McKesson, others to trial over opioidsNew York takes Teva, McKesson, others to trial over opioids
finance.yahoo.com - June 29 at 8:38 AM
Is Teva Pharmaceutical Industries (NYSE:TEVA) Using Too Much Debt?Is Teva Pharmaceutical Industries (NYSE:TEVA) Using Too Much Debt?
nasdaq.com - June 25 at 2:03 PM
EFV, TEVA, WIX, MLCO: Large Inflows Detected at ETFEFV, TEVA, WIX, MLCO: Large Inflows Detected at ETF
nasdaq.com - June 21 at 1:12 PM
Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors May Contribute to the Significant Under-Diagnosis of MigraineTeva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors May Contribute to the Significant Under-Diagnosis of Migraine
finance.yahoo.com - June 21 at 8:12 AM
New Data Supporting the Safety and Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European Academy of Neurology CongressNew Data Supporting the Safety and Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European Academy of Neurology Congress
finance.yahoo.com - June 21 at 8:12 AM
Liposomes Market: Facts, Figures and Analytical Insights, 2020 to 2027| Luye Pharma, CSPC, Shanghai New Asia and OthersLiposomes Market: Facts, Figures and Analytical Insights, 2020 to 2027| Luye Pharma, CSPC, Shanghai New Asia and Others
marketwatch.com - June 15 at 5:57 PM
Teva Pharmaceutical Industries Ltd. (TEVA) Moves 7.5% Higher: Will This Strength Last?Teva Pharmaceutical Industries Ltd. (TEVA) Moves 7.5% Higher: Will This Strength Last?
finance.yahoo.com - June 11 at 4:06 AM
A Key Opioid Trial Begins Today. What Investors Need to Know.A Key Opioid Trial Begins Today. What Investors Need to Know.
finance.yahoo.com - June 8 at 7:33 AM
July 23rd Options Now Available For Teva Pharmaceutical IndustriesJuly 23rd Options Now Available For Teva Pharmaceutical Industries
nasdaq.com - June 3 at 12:46 PM
Global Active Pharmaceutical Ingredients Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and ForecastsGlobal Active Pharmaceutical Ingredients Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
markets.businessinsider.com - June 1 at 11:13 PM
Cranial implants industry size is examined and is anticipated to value around USD 1.5 billion by the end of 2026. | ARCCranial implants industry size is examined and is anticipated to value around USD 1.5 billion by the end of 2026. | ARC
marketwatch.com - May 25 at 12:03 AM
NATCO PHARMA - HITS A NEW HIGHNATCO PHARMA - HITS A NEW HIGH
in.finance.yahoo.com - May 24 at 9:01 AM
Glioma Therapeutics Market Industry: A Latest Research Report to Share Market Insights and Dynamics 2021-2027Glioma Therapeutics Market Industry: A Latest Research Report to Share Market Insights and Dynamics 2021-2027
marketwatch.com - May 19 at 9:58 PM
Woodstock Sterile Solutions Adds Pharmaceutical Industry Veterans to its Board of DirectorsWoodstock Sterile Solutions Adds Pharmaceutical Industry Veterans to its Board of Directors
markets.businessinsider.com - May 19 at 11:57 AM
Global Preterm Birth Prevention and Management Market (2019 to 2029) – Industry Analysis and Opportunity AssessmentGlobal Preterm Birth Prevention and Management Market (2019 to 2029) – Industry Analysis and Opportunity Assessment
marketwatch.com - May 18 at 7:33 AM
Systemic Scleroderma Treatment Monitoring Market Industry Outlook, by Top Key Players: F. Hoffmann La Roche Ltd.; Johnson & Johnson Services, IncSystemic Scleroderma Treatment Monitoring Market Industry Outlook, by Top Key Players: F. Hoffmann La Roche Ltd.; Johnson & Johnson Services, Inc
marketwatch.com - May 15 at 4:28 AM
How The Covid-19 Vaccine Injected Billions Into Big Pharma—And Made Its Executives Very RichHow The Covid-19 Vaccine Injected Billions Into Big Pharma—And Made Its Executives Very Rich
forbes.com - May 14 at 5:22 PM
Global Survey 2021-2030: Oxcarbazepine Tablets Market Forecast- Whats The Future Scope Of Oxcarbazepine Tablets Industry In The Projected Years?Global Survey 2021-2030: Oxcarbazepine Tablets Market Forecast- What's The Future Scope Of Oxcarbazepine Tablets Industry In The Projected Years?
marketwatch.com - May 12 at 3:56 PM
The Top 5 Trades of Francisco Garcia Parames FirmThe Top 5 Trades of Francisco Garcia Parames' Firm
finance.yahoo.com - May 7 at 4:44 PM
Corcept Therapeutics Incorporated (CORT) Q1 2021 Earnings Call TranscriptCorcept Therapeutics Incorporated (CORT) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 7 at 6:43 AM
Interesting TEVA Call Options For June 25thInteresting TEVA Call Options For June 25th
nasdaq.com - May 6 at 7:01 PM
Worldwide Gastroparesis Industry to 2027 - Surging Investments and Financial Assistance for Research Presents OpportunitiesWorldwide Gastroparesis Industry to 2027 - Surging Investments and Financial Assistance for Research Presents Opportunities
markets.businessinsider.com - May 6 at 2:00 PM
Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United StatesTeva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United States
finance.yahoo.com - May 4 at 1:21 PM
Notable ETF Inflow Detected - IDEV, CCEP, TEVA, FUTUNotable ETF Inflow Detected - IDEV, CCEP, TEVA, FUTU
nasdaq.com - May 3 at 12:19 PM
Interesting TEVA Call Options For June 11thInteresting TEVA Call Options For June 11th
nasdaq.com - April 29 at 3:48 PM
This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.